United States · FDA National Drug Code directory

Losartan Potassium and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
65862-469_194eea48-8bc8-476d-a604-4b656222d5be
Product NDC
65862-469
Form
TABLET, FILM COATED
Composition / generic term
Losartan Potassium and Hydrochlorothiazide
Labeler
Aurobindo Pharma Limited
Marketing category
ANDA
Marketing start / end (source format)
20101006
Source listing expiry
20261231

Source-listed ingredients

  • LOSARTAN POTASSIUM — 100 mg/1
  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BLISTER PACK in 1 CARTON (65862-469-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 65862-469-10
  • 30 TABLET, FILM COATED in 1 BOTTLE (65862-469-30) · 65862-469-30
  • 5000 TABLET, FILM COATED in 1 BOTTLE (65862-469-59) · 65862-469-59
  • 90 TABLET, FILM COATED in 1 BOTTLE (65862-469-90) · 65862-469-90
  • 1000 TABLET, FILM COATED in 1 BOTTLE (65862-469-99) · 65862-469-99

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Losartan Potassium and Hydrochlorothiazide — United States | Molindra Medicines